Search

Introduction: The purpose of this descriptive study was to analyze the clinical, laboratory, anthropometric, and histological results of patients who underwent laparoscopic sleeve gastrectomy (LSG) before and three months after the operation. Materials and Methods: A total of 110 patients who were followed and underwent LSG between January 2021 and December 2021 were included in this study. Body mass index (BMI), waist and hip circumference, soft lean mass (SLM), percent body fat (PBF), and common laboratory parameters were evaluated before and three months after the LSG. Endoscopic biopsies and LSG specimens were examined by the pathology department. Results: The mean age of the patients was 40.8±11.3 years, and 78.4% were female. There was no significant difference in age in terms of gender (p=0.789). The mean age was significantly lower in patients without comorbid diseases and chronic drug use (p<0.001). There was a significant decrease in BMI, PBF, SLM, glucose, HOMA-IR, HbA1c, total cholesterol, and triglyceride values in the third month (all p's <0.001). A significant correlation was observed between PBF% change and SLM% change values at post-op 3rd month (r=0.332, p=0.001). BMI% and PBF% change showed a stronger correlation than BMI% and SLM% change with (r=0.447, p<0.001) and (r=0.253, p=0.016), respectively. Histopathologic findings of LSG revealed gastrointestinal stromal tumor in 2 cases, neuroendocrine hyperplasia in 2 cases, and intestinal metaplasia in 13 cases, which were detected incidentally. Conclusion: LSG is an effective treatment for obesity and associated comorbidities, with significant improvements observed in metabolic parameters, hypertension, and laboratory values. Careful monitoring and follow-up are essential to detect and treat potential histopathologic findings. [ABSTRACT FROM AUTHOR]

Objective: The capillary zone electrophoresis (CZE) and highperformance liquid chromatography (HPLC) methods were compared in terms of HbA2 measurement for the assessment of hemoglobinopathies. Materials and Methods: CZE was compared with HPLC for the evaluation of patients without hemoglobinopathy (n=321), with β-thalassemia trait (n=113), and with common (HbD-Punjab, E, C, S/A, and S/S) and rare (HbS/D, O-Arap, Lepore, G-Coushata, Setif, Hamadan, Q-Iran, and H) variants (n=21). The reference range for HbA2 was determined by CZE. Results: Among patients without hemoglobinopathy, the median (2.5th-97.5th percentiles) values were 97.4% (97.0-98.0%) and 97.5% (96.6-98.4%) for HbA (p=0.060) and 2.4% (1.6-3.0%) and 2.5% (1.6-3.1%) for HbA2 (p<0.001) by HPLC and CZE, respectively. The reference range for HbA2 was 1.6-3.1% by CZE. In the comparison of methods for HbA2, there was a constant error of 0.255 (confidence interval: 0.062-0.448) and bias of 0.10% (limit of agreement: 0.33- 0.53), and higher values were obtained with CZE. A strong correlation was observed between the methods (r=0.782). Interrater agreement was almost perfect for clinical diagnosis (=0.911). The two methods detected and identified the common variants similarly. All rare variants, except HbH by HPLC and HbS/D by CZE, were detected as separate peaks by both methods. Conclusion: The two methods were in agreement regarding the preliminary identification of β-thalassemia patients. Different Hb variants were detected by both methods but with possible methodological interference for HbA2 measurements. CZE is a reliable and simple alternative for the evaluation of hemoglobinopathies. The standardization of HbA2 measurements should be prioritized as more techniques become available in routine laboratory practice [ABSTRACT FROM AUTHOR]

Aim: It has been known for a long time that the presence of clinically silent hemoglobin (Hb) variants in blood samples could influence the measurement of glycohemoglobin (HbA1c) since these abnormal hemoglobins might interfere with some methodologies. In the present study we describe the first case of Hb Beckman in Turkey. Material and Methods: The variant was detected during the HbA1c measurement by cation exchange high performance chromatography (CE-HPLC) in a patient with diabetes mellitus. Since a HbA1c result could not be obtained by this method, the test was repeated by boronate affinity HPLC. Results: Further investigation performed in order to identify the variant revealed heterozygote Hb Beckman 135 GCT-GAT (Ala --> Asp) which explained the inappropriate HbA1c result by CE-HPLC. Conclusion: This new case of Hb Beckman is thought to be a modest contribution to the subject of abnormal hemoglobins that interfere the HbA1c measurement. [ABSTRACT FROM AUTHOR]

Introduction: The aim of this study was to evaluate the stability of urine collected in preservative tubes for chemistry strip analyses and particle counting to determine whether the transport of urine samples with all of their constituents is possible. Materials and methods: 275 pathologic urine specimens were included. Each urine sample was evaluated after 4, 8, 12, 24, and 48 hours of storage in BD Vacutainer® Plus Urinalysis Preservative (BD UAP) tubes and compared with refrigeration at 4 °C. All analyses were peformed on H-800 and FUS-200 automatic modular urine analyzers (Dirui Industry, Changchun, China). The kappa coefficients (κ), false positive (FP) and false negative (FN) rates were evaluated. κ > 0.8 was accepted as good agreement. Results: Haemoglobin (Hb), leucocyte esterase (LE), and protein (Pro) analyses should be performed within 4 hours, whereas glucose (Glc) was stable until the end of 48 hours in both storage conditions. Nitrite (Nit) was well preserved in BD UAP tubes for 24 hours but was stable only up to 8 hours at 4 °C. Bilirubin (Bil) had very high FN rates even at 4 hours in both conditions. The particle counting showed high FN rates for white blood cells (WBC) and red blood cells (RBC), whereas squamous epithelial cells (EC) were stable up to 8 hours in both conditions. Conclusions: Preanalytical requirements for both urine chemical strip analyses and particle counting in a unique sample were not met in either condition. Thus, the transfer of urine samples for centralization of urinalysis is not yet feasible. [ABSTRACT FROM AUTHOR]